Vergoeding 2015-2019 voor ATC-subgroep A10BB : Sulfonylureumderivaten
- Raming voor de totale Zvw-populatie
| 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|
| A10BB01 Glibenclamide | 85.983 | 60.900 | 50.858 | 51.397 | 56.333 |
| A10BB03 Tolbutamide | 1.924.600 | 1.561.200 | 1.361.400 | 1.250.900 | 1.435.400 |
| A10BB09 Gliclazide (Diamicron ®) | 3.158.000 | 3.646.200 | 4.235.800 | 5.424.600 | 6.393.500 |
| A10BB12 Glimepiride (Amaryl ®) | 1.073.600 | 891.820 | 872.280 | 764.530 | 764.620 |
| Totaal | 6.242.183 | 6.160.120 | 6.520.338 | 7.491.427 | 8.649.853 |